A Research Registry on Aggressive PitNETs
Recruiting
Observational Study
Endocrine Tumor
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Hospices Civils de Lyon · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To allow the identification of markers, it is necessary to extend research networks more widely to collect and properly explore aggressive pituitary tumours. The multidisciplinary consultation meeting (RCP), organised by the reference centre for rare diseases of the pituitary gland, dedicated to aggressive pituitary tumours and carcinomas (HYPOcare), which is unique in France and brings together n…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
* Inclusion Criteria :
* Patients with a diagnosis of pituitary tumour
* Patients whose file has been presented to the national HYPOcare RCP
* Exclusion Criteria :
* Patients objecting to participating in this research
Contacts
No contact information available.